Yvonne Li Net Worth & Insider Trades
Yvonne Li - See Remarks, Oncomed Pharmaceuticals Inc
What is Yvonne Li's Net Worth?
The current estimated net worth of Oncomed Pharmaceuticals Inc's See Remarks, Yvonne Li, is estimated to be about $18.04K . Yvonne Li owns about 59,734 units of Oncomed Pharmaceuticals Inc common stock. In the last year at Oncomed Pharmaceuticals Inc, Yvonne Li has sold an estimated value of $18.04K worth.
What is Yvonne Li's Past Insider Trading?
Yvonne Li's largest sale order was 5,062 units , worth over $13.55K on April 26, 2018. In total, Yvonne Li has made about 5 transactions over a year of their time at Oncomed Pharmaceuticals Inc. Yvonne Li usually trades in October and April, with the busiest year in 2018. The most recent transaction was a sale order of 927 units , worth over $1.87K on October 11, 2018.
Yvonne Li
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Yvonne Li's Salary in 2017?
As See Remarks of Oncomed Pharmaceuticals Inc, Yvonne Li has a total base salary of $347,619 . Yvonne Li received compensation valued at about $1,432,262 in 2017 after becoming See Remarks. The vast majority of their compensation came in the form of stock awards of $154,536 , option awards of $804,964 , and other earnings, plans or compensations of $125,143 .
What is Yvonne Li's' Mailing Address?
- Mailing address is C/o Oncomed Pharmaceuticals, Inc. 800 Chesapeake Drive Redwood City CA 94063 CA
Oncomed Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Total
|
|---|---|---|---|---|---|---|
| John A. Lewicki, Ph.D., | 2017 | $419,777 | $192,925 | $967,675 | $167,911 | $1,748,288 |
| John A. Lewicki, Ph.D., | 2016 | $407,550 | $141,750 | - | $146,718 | $696,018 |
| Paul Hastings, | 2017 | $551,127 | $169,650 | $1,857,110 | $60,624 | $2,638,511 |
| Paul Hastings, | 2016 | $535,075 | $158,760 | - | $264,862 | $958,697 |
| Sunil Patel, | 2017 | $406,117 | $183,600 | $939,700 | $167,780 | $1,697,197 |
| Austin Gurney, Ph.D., | 2017 | $365,612 | $154,536 | $804,964 | $116,996 | $1,442,108 |
| Alicia Hager, J.D., Ph.D., | 2017 | $347,619 | $154,536 | $804,964 | $125,143 | $1,432,262 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1302573/000156459018009577/omed-def14a_20180622.htm
What are Oncomed Pharmaceuticals Inc's Past Insider Trades?
Oncomed Pharmaceuticals Inc's most recent insider trade came on December 26, 2018 by Austin Gurney who sold 11,117 units worth $6.67K . In the last 5 years, insiders at Oncomed Pharmaceuticals Inc have sold an estimated value of $14.76M and bought an estimated value of $23.88M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Austin Gurney, See Remarks, John A Lewicki, President and CEO, and Alicia J Hager, SVP and General Counsel .
OncoMed Pharmaceuticals Inc Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||